Xarelto Linked to Uncontrollable Internal Bleeding and Death

On Behalf of | Aug 18, 2017 | Class Action

An anticoagulant, or blood-thinner, manufactured by Janssen Pharmaceuticals and marketed by Bayer Healthcare, Xarelto was represented as being the superior medication to reduce the incidence of stroke, deep vein thrombosis, and pulmonary embolisms. Studies, however, have found that Xarelto can lead to serious, uncontrollable, and life-threatening internal bleeding, and even death.

images (2).jpeg

Unlike warfarin and other blood-thinner medications, for which a high dose of Vitamin K can treat bleeding events, there is no known antidote or reversing agent for the bleeding or hemorrhaging caused by Xarelto, even with a doctor’s help.

To date, thousands of people — approximately 14,000, to be exact — have filed lawsuits across the country taking aim at Janssen and Bayer’s initial failure to design and manufacture the drug to eliminate this risk and their subsequent failure to warn of this significant risk.

The lawsuits have been consolidated in a federal court in Louisiana, known as a multi-district litigation (MDL) proceeding. There is still time to take action, but time is running short.

If you, a loved one, or someone you know was prescribed Xarelto and suffered internal bleeding or hemorrhaging, including gastrointestinal and abdominal bleeding, eye bleeding, or intracranial hemorrhaging, call us today. We can talk to you about your options, how the MDL process works, and how you can potentially recover for the sustained injuries.

Findlaw Network

Serving Client Throughout